Emerging technologies and the future of cardiovascular diseases management

Cardiovascular diseases (CVDs) are the first cause of death worldwide. An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Over three-quarters of CVD deaths take place in low- and middle-income countries. Out of the 17 million premature …

What the Regulators are Looking for in a LIMS Validation Plan

Validating LIMS is a fundamental requirement for GMP compliance. Where LIMS is used to store and process GMP data, it is imperative that the system accurately and reliably performs as expected. This is where the validation and implementation project play an important part in the lifecycle of a LIMS. It should be focused on aspects related to patient safety, …

The “other” LIMS functions

The analytical and reporting processes attributed to LIMS (LIS) are well documented and known to analysts, laboratory managers and directors. However, LIMS offer many valuable functions, often not explored, in terms of human resources (HR). As with so many functions in the new ways of business, HR is often not onsite every day, making the …